Bloomberg Talks

Moderna CEO Talks Company Earnings

May 2, 2024
Guest
Stephane Bancel
Modern CEO Stephane Bancel discusses company earnings and cost-cutting benefits in response to Covid business decline. Topics include balancing cost efficiency with innovation, progress on a melanoma vaccine, potential accelerated approval, and the impact of AI on drug production and clinical development.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 3min
2
Progress Update on Melanoma Vaccine and Criteria for Accelerated Approval
03:22 • 2min
3
The Impact of Artificial Intelligence on Drug Production and Clinical Development
05:21 • 4min